Detection and resistance research of producing AmpC β-lactamases or ESBLs in Enterobacter cloacae

LIU Jian-ming,NIE Xin-min,SUN Shen-hua,LIU Bei-zhan
DOI: https://doi.org/10.3969/j.issn.1005-8982.2008.21.006
2008-01-01
Abstract:Objective To investigate the clinical circumstance of Enterobacter cloacae producing AmpC β-lactamases or AmpC β-lactamases plus extended-spectrum β-lactamases(ESBLs), to assay the antimicrobial resistance of 13 drugs clinically in order to guide the appropriate choice to treat the infections caused by enterobacter cloacae.Methods AmpC β-lactamases and ESBLs producing clinical isolates were detected by three-dimensional extraction test, and the susceptibility test was detected by Kirby-Bauer(K-B).ResultsAmong 120 isolates of Enterobacter cloacae, produing AmpCβ-lactamases were 24 strains(20%), ESBLs were 30 strains(25%), Amp β-lactamases plus ESBLs(which is SSBL) were 15 strains(12.5%).SSBL strains of Enterobacter cloacae were higher than AmpC β-lactamases in resistent to Levofloxacin, Cefepime, Aztronem and Trimethoprim and sulphame-thoxazole, which is statistically sygnificant to stastics(P <0.05).SSBL strains showed higher resistance than ESBLs in Imipenem, Cefoxitin and Ciprofloxacin, which had relevence to stastics(P <0.05).SSBL strains were higher than SSBL neg-ative strains in resistant to Imipenem, Cefepime, Cefatriaxone and Ciprofloxacin, which had relevence to stastics(P < 0.05).Conclusion The main reason that the resistance to cephalosperin Ⅲ antibiotics caused by AmpC β-lacta-mases or ESBLs in Enterobacter cloacae, the prevalence of SSBL strains enhancing kinds of strains' resistance, one should accord with the detective result of resistent mechanism when treating the infections, considering antibiotics of carbapenems and quinolones according to the result.
What problem does this paper attempt to address?